GSK Consumer Q4 net up 11% at Rs 59 cr

GlaxoSmithkline Consumer Healthcare (GSKCH) today posted 10.73% rise in net profit at Rs 59.10 crore for the fourth quarter ended December, 2011.

The company had posted a net profit of Rs 53.37 crore in the corresponding period of previous fiscal.

Net sales of the company rose to Rs 602.05 crore for the fourth quarter ended December 31, 2011, compared to Rs 507.76 crore in the same period previous fiscal, GlaxoSmithkline said in filing to the Bombay Stock Exchange (BSE).

Commenting on the results, GSKCH Managing Director Zubair Ahmed said: "Despite high inflation in commodities, cost engineering programme helped the company deliver superior results."

The company's board, which met today, recommended a dividend at the rate of Rs 35 per equity share of Rs 10 each for the year ended December 31, 2011.

For the year ended December 31, 2011, the company posted a net profit of Rs 355.21 crore, compared to Rs 299.85 crore in the corresponding period of previous fiscal.

The company said it has appointed Jaiboy John Phillips as a wholetime director of the company with effect from today in the casual vacancy caused by the resignation of Director- Operations Praveen K Gupta.

Shares of GSKCH today closed at Rs 2,636.60 on the BSE, down 0.37% from previous close.

image
Business Standard
177 22
Business Standard

GSK Consumer Q4 net up 11% at Rs 59 cr

Press Trust of India  |  New Delhi 



GlaxoSmithkline Consumer Healthcare (GSKCH) today posted 10.73% rise in net profit at Rs 59.10 crore for the fourth quarter ended December, 2011.

The company had posted a net profit of Rs 53.37 crore in the corresponding period of previous fiscal.

Net sales of the company rose to Rs 602.05 crore for the fourth quarter ended December 31, 2011, compared to Rs 507.76 crore in the same period previous fiscal, GlaxoSmithkline said in filing to the Bombay Stock Exchange (BSE).

Commenting on the results, GSKCH Managing Director Zubair Ahmed said: "Despite high inflation in commodities, cost engineering programme helped the company deliver superior results."

The company's board, which met today, recommended a dividend at the rate of Rs 35 per equity share of Rs 10 each for the year ended December 31, 2011.

For the year ended December 31, 2011, the company posted a net profit of Rs 355.21 crore, compared to Rs 299.85 crore in the corresponding period of previous fiscal.

The company said it has appointed Jaiboy John Phillips as a wholetime director of the company with effect from today in the casual vacancy caused by the resignation of Director- Operations Praveen K Gupta.

Shares of GSKCH today closed at Rs 2,636.60 on the BSE, down 0.37% from previous close.

RECOMMENDED FOR YOU

GSK Consumer Q4 net up 11% at Rs 59 cr

The company had posted a net profit of Rs 53.37 crore in the corresponding period of previous fiscal.

GlaxoSmithkline Consumer Healthcare (GSKCH) today posted 10.73% rise in net profit at Rs 59.10 crore for the fourth quarter ended December, 2011.

The company had posted a net profit of Rs 53.37 crore in the corresponding period of previous fiscal.

Net sales of the company rose to Rs 602.05 crore for the fourth quarter ended December 31, 2011, compared to Rs 507.76 crore in the same period previous fiscal, GlaxoSmithkline said in filing to the Bombay Stock Exchange (BSE).

Commenting on the results, GSKCH Managing Director Zubair Ahmed said: "Despite high inflation in commodities, cost engineering programme helped the company deliver superior results."

The company's board, which met today, recommended a dividend at the rate of Rs 35 per equity share of Rs 10 each for the year ended December 31, 2011.

For the year ended December 31, 2011, the company posted a net profit of Rs 355.21 crore, compared to Rs 299.85 crore in the corresponding period of previous fiscal.

The company said it has appointed Jaiboy John Phillips as a wholetime director of the company with effect from today in the casual vacancy caused by the resignation of Director- Operations Praveen K Gupta.

Shares of GSKCH today closed at Rs 2,636.60 on the BSE, down 0.37% from previous close.

image
Business Standard
177 22
Widgets Magazine

More News

  • Reliance Jio RJio extends preview offer to Gionee, Karbon, Lava users
  • Chairman of Piramal Healthcare Ltd. Ajay Piramal gestures as he speaks during a news conference in Mumbai Ajay Piramal, Venu Srinivasan join Tata Sons' board
Widgets Magazine
Widgets Magazine

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard